Treatment Horizons

LifeGuide Running Into Options An NNRTI candidate seeks to keep on track to expand therapies by Chael Needle In this next-generation era of anti-HIV meds, research and development...

A bacterium with a live biotherapeutic grows into a microbicide candidate by Chael Needle LifeGuide The development of female-initiated HIV prevention methods—female condoms, antiretroviral treatment as prevention,...

Treatment Horizons Another Kind of Morning HIV therapeutic vaccines try to come of age by Mariel Selbovitz, MPJ, and David Miller Despite over three decades of research on...

Study results show immediate treatment holds promise as a prevention tool by Chael Needle Treatment and prevention make good bedfellows. That’s the idea underscoring the results...

The Power of Two Dual regimens show promise in clinical trials by Chael Needle At the International AIDS Conference in Amsterdam last July, ViiV Healthcare shared its...

If we think of HIV as carrying a kind of a malware that takes over human T cells and turns them into a machine...

The 6th IAS Pathogenesis Conference doesn't really end after the closing session by David Miller In 1987 I attended my first AIDS conference, beginning twenty-four years...

LifeGuide Dr. C. Everett Koop Revisits a Time When Neither Treatment nor Testing Existed by Chael Needle Knowing he had to face the micromanaging tendencies and...

Therapeutic Vaccine Research Toward a Functional Cure Shows Promise by Jeannie Wraight Until recently, therapeutic vaccines and immune-based therapies (IBTs) were all but shunned by the...

Treatment Horizons by Chael Needle Hill & Mountain? Weakened federal support of HIV/AIDS services puts our health at risk President Obama’s fiscal year 2014 budget plan includes...